Achieving Targeted Treatment Outcomes in IBD
Silvio Danese, MD, PhD, Bruce Sands, MD, and Jean-Frederic Colombel, MD, share their insights on the current landscape of ulcerative colitis treatment, focusing on the role of biologic therapies, the emerging concept of dual advanced therapy, and various monitoring methods used to assess treatment progress, ensuring optimal patient outcomes and timely adjustment of therapeutic strategies when needed.
EP. 1: Treat-to-target in Inflammatory Bowel Disease
June 10th 2024Medical experts in inflammatory bowel disease (IBD) define the concept of "treat-to-target" within the context of IBD and provide current recommendations on treatment targets for ulcerative colitis and Crohn's disease, the two main forms of IBD.
Watch
EP. 2: Recommended Targets When Treating Ulcerative Colitis/Crohn’s Disease in Clinic
June 10th 2024Silvio Danese, MD, PhD; Bruce Sands, MD, and Jean-Frederic Colombel, MD, discuss their preferred recommended targets for managing ulcerative colitis (UC) or Crohn's disease (CD), emphasizing the aggressive approach required to achieve these targets effectively.
Watch
EP. 3: Transmural Healing and Monitoring in Ulcerative Colitis and Crohn’s Disease
July 5th 2024Expert gastroenterologists delve into the concept of transmural healing as a treatment target for both ulcerative colitis and Crohn's disease, sharing insights on their preferred timeframes for reassessing treatment progress, monitoring methods, and the effectiveness of intestinal ultrasounds in the management of these conditions.
Watch
EP. 4: Implementing Treat to Target in the Long-term in Inflammatory Bowel Disease
July 5th 2024Expert panelists discuss the implementation of a treat-to-target approach for the long-term management of inflammatory bowel disease (IBD), drawing upon data from the STARDUST and REACT-2 trials to support their recommendations and insights into optimizing patient outcomes through this strategy.
Watch
